We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Incubators Incorporate Hydrogen Peroxide Vapor Decontamination Package

By LabMedica International staff writers
Posted on 13 Dec 2011
A novel decontamination system for CO2 incubators prevents growth of microorganisms and safeguards precious cell cultures.

The new line of incubators marketed by Sanyo (Nijverheidsweg, the Netherlands) boasts a unique hydrogen peroxide vapor decontamination option that provides complete decontamination while limiting incubator downtime to less than three hours.

This option, which is available on the MCO-19AIC CO2 and MCO-19M multigas incubators, is a low temperature process with no heat stress on electrical components and no impact on adjacent equipment and the surrounding environment.

The process depends on seven-minutes of incubation with hydrogen peroxide vapors followed by 90 minutes under the UV lamp, which reduces the hydrogen peroxide to water vapor and oxygen. The incubator’s interior fan circulates sterile air throughout the chamber during the entire cycle.

The hydrogen peroxide system is fully verified and is especially suitable for use in highly demanding pharmaceutical and biotechnology applications, such as monoclonal antibody production.

Related Links:

Sanyo




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
POC Immunoassay Analyzer
Procise DX
Clinical Informatics Platform
CLARION™

Latest BioResearch News

New Findings Clarify Molecular Drivers of Rare Small Intestinal Cancer
13 Dec 2011  |   BioResearch

Lung Cancer Study Reveals Cellular Program Behind Therapy Resistance
13 Dec 2011  |   BioResearch

Tumor Genome Marker May Predict Treatment Benefit in Pediatric Cancers
13 Dec 2011  |   BioResearch



ADLM